✦ LIBER ✦

Pexelizumab fails to inhibit assembly of the terminal complement complex in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Insight from a substudy of the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial

✍ Scribed by Catherine Martel; Christopher B. Granger; Marta Ghitescu; Amanda Stebbins; Annik Fortier; Paul W. Armstrong; Arnaud Bonnefoy; Pierre Theroux

Book ID: 116192780
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 594 KB
Volume: 164
Category: Article
ISSN: 1097-6744
DOI: 10.1016/j.ahj.2012.04.007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Assessment of Pexelizumab in Acute Myoca

Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI): A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of pexelizumab in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention

✍ Paul W. Armstrong; Peter X. Adams; Hussein R. Al-Khalidi; Christian Hamm; David 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 179 KB

Is visual interpretation of coronary epi

Is visual interpretation of coronary epicardial flow reliable in patients with ST-elevation myocardial infarction undergoing primary angioplasty? Insights from the angiographic substudy of the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial

✍ Osama Alhadramy; Cynthia M. Westerhout; Sorin J. Brener; Christopher B. Granger; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 320 KB

Does silent myocardial infarction add pr

Does silent myocardial infarction add prognostic value in ST-elevation myocardial infarction patients without a history of prior myocardial infarction? Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Trial

✍ Mustafa Toma; Yuling Fu; Justin A. Ezekowitz; Finlay A. McAlister; Cynthia M. We 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 337 KB

Variations in practice and outcomes in p

Variations in practice and outcomes in patients undergoing primary percutaneous coronary intervention in the United States and Canada: Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI) trial

✍ Rajendra H. Mehta; Padma Kaul; Renato D. Lopes; Manesh R. Patel; Yinggan Zheng; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Predictors of Reperfusion Delay in Patie

Predictors of Reperfusion Delay in Patients With Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention from the HORIZONS-AMI Trial

✍ James C. Blankenship; Kimberly A. Skelding; Thomas D. Scott; Peter B. Berger; He 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 198 KB

Standard versus high loading doses of cl

Standard versus high loading doses of clopidogrel in Asian patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: Insights from the Korea Acute Myocardial Infarction Registry

✍ Gen-Min Lin; Yi-Hwei Li; Kai-Min Chu; Chih-Lu Han 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 56 KB